Colour Doppler ultrasound of spiral artery blood flow in the prediction of pre-eclampsia and intrauterine growth restriction

Juliana Gebb, Pe'er Dar

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Pre-eclampsia and intrauterine growth restriction are responsible for significant maternal and fetal morbidity and mortality worldwide. Identifying pregnancies at highest risk for their development would allow increased surveillance in individual pregnancies and also allow therapeutic trials to decrease their incidences in the future. To date, multiple attempts to develop a screening test for these disorders have met with limited success. Proposed screening methods have included maternal serum biochemical parameters as well as ultrasonographic markers. Uterine artery Doppler, direct evaluation of the spiral arteries using colour and spectral Doppler, three-dimensional placental volume analysis and, most recently, three-dimensional power Doppler angiography have all been suggested. Although an adequate screening method remains elusive, advances in ultrasound technology have improved our ability to observe the pathophysiologic changes that occur with these conditions early in pregnancy, bringing us closer to a reproducible screening model.

Original languageEnglish (US)
Pages (from-to)355-366
Number of pages12
JournalBest Practice and Research: Clinical Obstetrics and Gynaecology
Volume25
Issue number3
DOIs
StatePublished - Jun 2011

Fingerprint

Doppler Ultrasonography
Pre-Eclampsia
Arteries
Color
Mothers
Fetal Mortality
High-Risk Pregnancy
Uterine Artery
Pregnancy
Growth
Angiography
Technology
Morbidity
Incidence
Serum
Therapeutics

Keywords

  • colour Doppler ultrasound
  • intrauterine growth restriction
  • pre-eclampsia
  • spiral artery
  • three-dimensional power Doppler

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

@article{20fc1da34fb84ae3a96906cffecab1ef,
title = "Colour Doppler ultrasound of spiral artery blood flow in the prediction of pre-eclampsia and intrauterine growth restriction",
abstract = "Pre-eclampsia and intrauterine growth restriction are responsible for significant maternal and fetal morbidity and mortality worldwide. Identifying pregnancies at highest risk for their development would allow increased surveillance in individual pregnancies and also allow therapeutic trials to decrease their incidences in the future. To date, multiple attempts to develop a screening test for these disorders have met with limited success. Proposed screening methods have included maternal serum biochemical parameters as well as ultrasonographic markers. Uterine artery Doppler, direct evaluation of the spiral arteries using colour and spectral Doppler, three-dimensional placental volume analysis and, most recently, three-dimensional power Doppler angiography have all been suggested. Although an adequate screening method remains elusive, advances in ultrasound technology have improved our ability to observe the pathophysiologic changes that occur with these conditions early in pregnancy, bringing us closer to a reproducible screening model.",
keywords = "colour Doppler ultrasound, intrauterine growth restriction, pre-eclampsia, spiral artery, three-dimensional power Doppler",
author = "Juliana Gebb and Pe'er Dar",
year = "2011",
month = "6",
doi = "10.1016/j.bpobgyn.2011.01.008",
language = "English (US)",
volume = "25",
pages = "355--366",
journal = "Best Practice and Research in Clinical Obstetrics and Gynaecology",
issn = "1521-6934",
publisher = "Bailliere Tindall Ltd",
number = "3",

}

TY - JOUR

T1 - Colour Doppler ultrasound of spiral artery blood flow in the prediction of pre-eclampsia and intrauterine growth restriction

AU - Gebb, Juliana

AU - Dar, Pe'er

PY - 2011/6

Y1 - 2011/6

N2 - Pre-eclampsia and intrauterine growth restriction are responsible for significant maternal and fetal morbidity and mortality worldwide. Identifying pregnancies at highest risk for their development would allow increased surveillance in individual pregnancies and also allow therapeutic trials to decrease their incidences in the future. To date, multiple attempts to develop a screening test for these disorders have met with limited success. Proposed screening methods have included maternal serum biochemical parameters as well as ultrasonographic markers. Uterine artery Doppler, direct evaluation of the spiral arteries using colour and spectral Doppler, three-dimensional placental volume analysis and, most recently, three-dimensional power Doppler angiography have all been suggested. Although an adequate screening method remains elusive, advances in ultrasound technology have improved our ability to observe the pathophysiologic changes that occur with these conditions early in pregnancy, bringing us closer to a reproducible screening model.

AB - Pre-eclampsia and intrauterine growth restriction are responsible for significant maternal and fetal morbidity and mortality worldwide. Identifying pregnancies at highest risk for their development would allow increased surveillance in individual pregnancies and also allow therapeutic trials to decrease their incidences in the future. To date, multiple attempts to develop a screening test for these disorders have met with limited success. Proposed screening methods have included maternal serum biochemical parameters as well as ultrasonographic markers. Uterine artery Doppler, direct evaluation of the spiral arteries using colour and spectral Doppler, three-dimensional placental volume analysis and, most recently, three-dimensional power Doppler angiography have all been suggested. Although an adequate screening method remains elusive, advances in ultrasound technology have improved our ability to observe the pathophysiologic changes that occur with these conditions early in pregnancy, bringing us closer to a reproducible screening model.

KW - colour Doppler ultrasound

KW - intrauterine growth restriction

KW - pre-eclampsia

KW - spiral artery

KW - three-dimensional power Doppler

UR - http://www.scopus.com/inward/record.url?scp=79955815318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955815318&partnerID=8YFLogxK

U2 - 10.1016/j.bpobgyn.2011.01.008

DO - 10.1016/j.bpobgyn.2011.01.008

M3 - Article

C2 - 21377937

AN - SCOPUS:79955815318

VL - 25

SP - 355

EP - 366

JO - Best Practice and Research in Clinical Obstetrics and Gynaecology

JF - Best Practice and Research in Clinical Obstetrics and Gynaecology

SN - 1521-6934

IS - 3

ER -